These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 11328741
1. CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis. Kilmartin DJ, Fletcher ZJ, Almeida JA, Liversidge J, Forrester JV, Dick AD. Invest Ophthalmol Vis Sci; 2001 May; 42(6):1285-92. PubMed ID: 11328741 [Abstract] [Full Text] [Related]
2. Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. Murphy CC, Greiner K, Plskova J, Duncan L, Frost NA, Forrester JV, Dick AD. Arch Ophthalmol; 2005 May; 123(5):634-41. PubMed ID: 15883282 [Abstract] [Full Text] [Related]
3. Interferon-alpha: a key factor in autoimmune disease? Plskova J, Greiner K, Muckersie E, Duncan L, Forrester JV. Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3946-50. PubMed ID: 16936109 [Abstract] [Full Text] [Related]
4. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis]. Greiner K, Varikkara M, Santiago C, Forrester JV. Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257 [Abstract] [Full Text] [Related]
5. Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients. Weigel G, Griesmacher A, Karimi A, Zuckermann AO, Grimm M, Mueller MM. J Heart Lung Transplant; 2002 Oct; 21(10):1074-9. PubMed ID: 12398872 [Abstract] [Full Text] [Related]
6. Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors. Meloni F, Morosini M, Solari N, Bini F, Vitulo P, Arbustini E, Pellegrini C, Fietta AM. Int Immunopharmacol; 2006 Dec 20; 6(13-14):2002-10. PubMed ID: 17161354 [Abstract] [Full Text] [Related]
7. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I. Starska K, Głowacka E, Kulig A, Lewy-Trenda I, Bryś M, Lewkowicz P. Folia Histochem Cytobiol; 2011 Dec 20; 49(4):579-92. PubMed ID: 22252752 [Abstract] [Full Text] [Related]
8. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, Kangave D, Al-Muammar AM. Acta Ophthalmol; 2012 Dec 20; 90(8):e603-8. PubMed ID: 22971163 [Abstract] [Full Text] [Related]
9. Immune Profiling of T Cells Infiltrating Vitreous Humor in Tubercular Uveitis. Sharma RK, Gupta V, Bansal R, Sharma K, Gupta A, Sachdeva N. Immunol Invest; 2018 Aug 20; 47(6):615-631. PubMed ID: 29733740 [Abstract] [Full Text] [Related]
10. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential. Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, Wegenka UM, Nakayama T, Niess JH. J Immunol; 2012 Feb 15; 188(4):2001-13. PubMed ID: 22250092 [Abstract] [Full Text] [Related]
11. Decrease of CD69 levels on TCR Vα7.2+CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients. Yong YK, Tan HY, Saeidi A, Rosmawati M, Atiya N, Ansari AW, Rajarajeswaran J, Vadivelu J, Velu V, Larsson M, Shankar EM. Innate Immun; 2017 Jul 15; 23(5):459-467. PubMed ID: 28606013 [Abstract] [Full Text] [Related]
13. Increased CD4+ expression and decreased IL-10 in the anterior chamber in idiopathic uveitis. Calder VL, Shaer B, Muhaya M, Mclauchlan M, Pearson RV, Jolly G, Towler HM, Lightman S. Invest Ophthalmol Vis Sci; 1999 Aug 15; 40(9):2019-24. PubMed ID: 10440256 [Abstract] [Full Text] [Related]
14. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients]. Kılınçkaya Doğan H, Mutlu E, Köksoy S, Yılmaz VT, Koçak H, Çolak D, Mutlu D, Günseren F, Dinçkan A, Aliosmanoğlu İ, Süleymanlar G, Gültekin M. Mikrobiyol Bul; 2016 Apr 15; 50(2):224-35. PubMed ID: 27175495 [Abstract] [Full Text] [Related]
15. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses. Berry V, Magill A, Yost M, Janosky J, Sindhi R. Cytometry A; 2006 Feb 15; 69(2):95-103. PubMed ID: 16369935 [Abstract] [Full Text] [Related]
16. Expression of CD69 on T-cell subsets in HIV-1 disease. Pitsios C, Dimitrakopoulou A, Tsalimalma K, Kordossis T, Choremi-Papadopoulou H. Scand J Clin Lab Invest; 2008 Feb 15; 68(3):233-41. PubMed ID: 17917998 [Abstract] [Full Text] [Related]
17. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II. Starska K, Głowacka E, Kulig A, Lewy-Trenda I, Bryś M, Lewkowicz P. Folia Histochem Cytobiol; 2011 Feb 15; 49(4):593-603. PubMed ID: 22252753 [Abstract] [Full Text] [Related]
18. Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts. Eggenhofer E, Steinmann JF, Renner P, Slowik P, Piso P, Geissler EK, Schlitt HJ, Dahlke MH, Popp FC. Transpl Immunol; 2011 Apr 15; 24(3):157-63. PubMed ID: 21194567 [Abstract] [Full Text] [Related]